AndreaBozzo/ceres-open-data-index huggingface dataset:
Compound 529648: Kaur-16-en-19-al

Chemical compound data from PubChem database. IUPAC Name: 5,9-dimethyl-14-methylidenetetracyclo[11.2.1.01,10.04,9]hexadecane-5-carbaldehyde. Molecular Formula: C20H30O. Molecular Weight: 286.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530457: p-Toluic acid, 2-(1-adamantyl)ethyl ester

Chemical compound data from PubChem database. IUPAC Name: 2-(1-adamantyl)ethyl 4-methylbenzoate. Molecular Formula: C20H26O2. Molecular Weight: 298.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528436: 1-Decene, 4,8-dimethyl

Chemical compound data from PubChem database. IUPAC Name: 4,8-dimethyldec-1-ene. Molecular Formula: C12H24. Molecular Weight: 168.32. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Genetic studies of the Roma (Gypsies): a review

Background
          Data provided by the social sciences as well as genetic research suggest that the 8-10 million Roma (Gypsies) who live in Europe today are best described as a conglomerate of genetically isolated founder populations. The relationship between the traditional social structure observed by the Roma, where the Group is the primary unit, and the boundaries, demographic history and biological relatedness of the diverse founder populations appears complex and has not been addressed by population genetic studies.
        
        
          Results
          Recent medical genetic research has identified a number of novel, or previously known but rare conditions, caused by private founder mutations. A summary of the findings, provided in this review, should assist diagnosis and counselling in affected families, and promote future collaborative research. The available incomplete epidemiological data suggest a non-random distribution of disease-causing mutations among Romani groups.
        
        
          Conclusion
          Although far from systematic, the published information indicates that medical genetics has an important role to play in improving the health of this underprivileged and forgotten people of Europe. Reported carrier rates for some Mendelian disorders are in the range of 5 -15%, sufficient to justify newborn screening and early treatment, or community-based education and carrier testing programs for disorders where no therapy is currently available. To be most productive, future studies of the epidemiology of single gene disorders should take social organisation and cultural anthropology into consideration, thus allowing the targeting of public health programs and contributing to the understanding of population structure and demographic history of the Roma.
Patent AT-E401613-T1: [Translated] VIDEO DISTRIBUTION SYSTEM

Movies are distributed to customer households in a secure format on digital media such as optical disks for playing back via proprietary set-top boxes (14). A system operator produces movie disks in large quantities and delivers the disks to widely geographically dispersed distribution agents. Agents produce copies of the disks with unique agent identification codes embedded therein, and distribute the disks to local customers who have compatible playback devices. When customers view movies, information identifying the movie and a distribution agent who is responsible for the movie being distributed to that customer are communicated to the central computer of the system operator (20). The content providers are then paid royalties due and responsible distribution agents are compensated.
National Survey of Substance Abuse Treatment Services (N-SSATS): 2011 Data on Substance Abuse Treatment Facilities

This report presents results from the 2011 National Survey of Substance Abuse Treatment Services (N-SSATS), an annual census of facilities providing substance abuse treatment. Conducted by the Substance Abuse and Mental Health Services Administration (SAMHSA), the N-SSATS is designed to collect data on the location, characteristics, and use of alcohol and drug abuse treatment facilities and services throughout the 50 states, the District of Columbia, and other U.S. jurisdictions.
Prevention: Stabilizing Families Through TANF

This Child Welfare Information Gateway Podcast is available on Apple Podcasts
  
  

, GooglePlay
  
  

, Spotify
  
  

, Stitcher
  
  

, SoundCloud
  
  

, and the Child Welfare Information Gateway
  
  

 website. Subscribe to receive new episodes as they are released.

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 525147: Diethylene glycol, monoallyl ether, acetate

Chemical compound data from PubChem database. IUPAC Name: 2-(2-prop-2-enoxyethoxy)ethyl acetate. Molecular Formula: C9H16O4. Molecular Weight: 188.22. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 529284: 3-Heptyne, 2,2,5,6,6-pentamethyl

Chemical compound data from PubChem database. IUPAC Name: 2,2,5,6,6-pentamethylhept-3-yne. Molecular Formula: C12H22. Molecular Weight: 166.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528325: Butyl furfuryl sulfide

Chemical compound data from PubChem database. IUPAC Name: 1-(butylsulfanylmethyl)cyclopenta-1,3-diene. Molecular Formula: C10H16S. Molecular Weight: 168.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
U.S. State, Territorial, and County Stay-At-Home Orders: March 15-May 5 by County by Day

State, territorial, and county executive orders, administrative orders, resolutions, and proclamations are collected from government websites and cataloged and coded using Microsoft Excel by one coder with one or more additional coders conducting quality assurance.

Data were collected to determine when individuals in states, territories, and counties were subject to executive orders, administrative orders, resolutions, and proclamations for COVID-19 that require or recommend people stay in their homes.

These data are derived from the publicly available state, territorial, and county executive orders, administrative orders, resolutions, and proclamations (“orders”) for COVID-19 that expressly require or recommend individuals stay at home found by the CDC, COVID-19 Community Intervention and At-Risk Task Force, Monitoring and Evaluation Team & CDC, Center for State, Tribal, Local, and Territorial Support, Public Health Law Program from March 15 through May 5, 2020. These data will be updated as new orders are collected. Any orders not available through publicly accessible websites are not included in these data. Only official copies of the documents or, where official copies were unavailable, official press releases from government websites describing requirements were coded; news media reports on restrictions were excluded. Recommendations not included in an order are not included in these data. These data do not include mandatory business closures, curfews, or limitations on public or private gatherings. These data do not necessarily represent an official position of the Centers for Disease Control and Prevention.
Patent AT-E399706-T1: [Translated] QUICK RELEASE FOR ATTACHING A GAS BOTTLE TO A STRIP

The device has a part fixed to a bottle by straps (3, 4) and presenting two vertical passages. Another part is fixed to a splash plate and supports the former part. The latter part is equipped with vertical rods directed upwards on which the passages are threaded. The latter part is constituted of a base to support the former part. A nozzle of the bottle is connected to a pressure reducing valve fixed to the plate, by screwing. Independent claims are also included for the following: (a) a splash plate (b) a compressed gas bottle.
No effects on myocardial ischaemia in patients with stable ischaemic heart disease after treatment with ramipril for 6 months

Objective
          To assess the effects of a 6-month angiotensin-converting enzyme (ACE) inhibitor intervention on myocardial ischaemia.
        
        
          Method
          We randomized 389 patients with stable coronary artery disease to double-blind treatment with ramipril 5 mg/day (n = 133), ramipril 1.25 mg/day (n = 133), or placebo (n = 123). Forty-eight-hour ambulatory electrocardiography was performed at baseline, and after 1 and 6 months.
        
        
          Results
          Relevant baseline variables were similar in all groups. Changes over 6 months in duration of ≥ 1 mm ST-segment depression (STD), total ischaemic burden and maximum STD did not differ significantly between the treatment groups. There was no difference in the frequency of adverse events between the groups.
        
        
          Conclusion
          ACE inhibitor treatment has little impact on incidence and severity of myocardial ischaemia in patients with stable ischaemic heart disease.
Emergency Department Visits for Drug-Related Suicide Attempts Have Increased

This spotlight uses data from the Drug Abuse Warning Network (DAWN) to examine emergency department visits related to suicide attempts that involved drugs. There was an overall increase in drug-related suicide attempts from 2005 to 2011 (for patients ages 12 and older).  The report also examines the trends for individual age groups (12-17, 18-29,  30-44, 45-64, and 65 and older).
Patent AT-E399638-T1: [Translated] METHOD FOR PRODUCING MULTI-LAYER ARTICLES WITH SPECIAL VISUAL EFFECTS

The present invention relates to a multilayer article, wherein said multilayer article comprises: (i) a first layer comprising an acrylic resin; (ii) at least one translucent second layer comprising (a) an acrylic resin, optionally further comprising an impact modifier; (b) a rubber modified thermoplastic resin composition; (c) optionally a rheology modifier; and (d) a visual effects additive; (iii) a third layer comprising an acrylonitrile-butadiene-styrene (ABS) resin; and (iv) an optional backing layer comprising either a thermosetting polymer substrate, optionally fiber-reinforced, or glass filled ABS resin.
COVID-19 Hospital Data Coverage Summary

<p><b>After May 3, 2024, this dataset and webpage will no longer be updated because hospitals are no longer required to report data on COVID-19 hospital admissions, and hospital capacity and occupancy data, to HHS through CDC’s National Healthcare Safety Network. Data voluntarily reported to NHSN after May 1, 2024, will be available starting May 10, 2024, at <a href="https://covid.cdc.gov/covid-data-tracker/#hospitalizations-landing">COVID Data Tracker Hospitalizations</a>.</b></p>

This report shows a summary of the percent compliance by different hospital provider types. <br><br>
<li>6/17/23 - With the new 28-day compliance reporting period, CoP reports will be posted <b>every 4 weeks</b>.</li><br>
<li>9/12/2021 - To view other COVID-19 Hospital Data Coverage datasets, follow this link to view summary page:
https://healthdata.gov/stories/s/ws49-ddj5 </li>
ALW Assisted Living Facilities

Assisted Living Waiver (ALW) eligible individuals are those who are enrolled in Medi-Cal and meet the level of care provided in a nursing facility due to their medical needs. Individuals with Medi-Cal benefits that include a share of cost may not enroll in the ALW. This dataset contains the provider number, provider legal name, provider business name, capacity per provider enrollment, provider physical location, provider counties and provider phone number  of facilities enrolled in the ALW program. Data as of 1/1/2023
Compound 528073: 2-Thiophenemethanol, TMS

Chemical compound data from PubChem database. IUPAC Name: trimethyl(thiophen-2-ylmethylsulfanyl)silane. Molecular Formula: C8H14S2Si. Molecular Weight: 202.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525485: 4-Thia-1-hexanethiol

Chemical compound data from PubChem database. IUPAC Name: 3-ethylsulfanylpropane-1-thiol. Molecular Formula: C5H12S2. Molecular Weight: 136.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526566: 11,23-Dimethylpentatriacontane

Chemical compound data from PubChem database. IUPAC Name: 11,23-dimethylpentatriacontane. Molecular Formula: C37H76. Molecular Weight: 521.0. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Improvements to parallel plate flow chambers to reduce reagent and cellular requirements

Background
          The parallel plate flow chamber has become a mainstay for examination of leukocytes under physiologic flow conditions. Several design modifications have occurred over the years, yet a comparison of these different designs has not been performed. In addition, the reagent requirements of many designs prohibit the study of rare leukocyte populations and require large amounts of reagents.
        
        
          Results
          In this study, we evaluate modifications to a newer parallel plate flow chamber design in comparison to the original parallel plate flow chamber described by Lawrence et al. We show that modifications in the chamber size, internal tubing diameters, injection valves, and a recirculation design may dramatically reduce the cellular and reagent requirements without altering measurements.
        
        
          Conclusions
          These modifications are simple and easily implemented so that study of rare leukocyte subsets using scarce or expensive reagents can occur.
Publications Using SAMHSA Data4.12b Facilities offering services in sign language for the hearing impaired and in languages other than English, by facility operation and primary focus of facility: 2011. Percent

This is a National Survey of Substance Abuse Treatment Services (N-SSATS) data table showing facilities offering services in sign language for the hearing impaired and in languages other than English, by facility operation and primary focus of facility in 2011. N-SSATS is designed to collect data on the location, characteristics, and use of alcohol and drug abuse treatment facilities and services throughout the 50 States, the District of Columbia, and other U.S. jurisdictions.
Compound 525386: 2,5-Dithiaoctane

Chemical compound data from PubChem database. IUPAC Name: 1-(2-methylsulfanylethylsulfanyl)propane. Molecular Formula: C6H14S2. Molecular Weight: 150.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2010 State Profile — North Dakota

This state profile includes data from facilities in North Dakota that reported to N-SSATS for the survey reference date March 31, 2010. Data were collected on the location, characteristics, services offered, and number of clients in treatment at alcohol and drug abuse treatment facilities (both public and private) in North Dakota. In North Dakota, 57 substance abuse treatment facilities were included in the 2010 N-SSATS, reporting that there were 2,124 clients in substance abuse treatment on March 31, 2010. The survey response rate in North Dakota was 95.1%.
Severe reperfusion lung injury after double lung transplantation

Aim
          To demonstrate the effects of combined inhaled nitric oxide and surfactant replacement as treatment for acute respiratory distress syndrome. This treatment has not previously been documented for reperfusion injury after double lung transplantation.
        
        
          Method
          A 24-year-old female with cystic fibrosis underwent double lung transplantation. During implantation of the second lung a marked increase in pulmonary artery pressure associated with systemic hypotension, hypoxemia and low cardiac output were observed. Notwithstanding the patient received support from cardiovascular drugs and pulmonary vasodilators cardiopulmonary by-pass was necessary. In the intensive care unit the patient received the same drug support, inhaled nitric oxide and two bronchoscopic applications of bovine surfactant.
        
        
          Results
          A rapid improvement in PaO2/FiO2 within 2–3 hours of administration of surfactant was seen. The patient is well at follow-up 1 year post-transplant.
        
        
          Conclusion
          There is a potential role for a combined therapy with inhaled nitric oxide and surfactant replacement in reperfusion injury after lung transplantation.
Compound 525842: N,N-Dimethyl-N'-nonyl-propionamidine

Chemical compound data from PubChem database. IUPAC Name: N,N-dimethyl-N'-nonylpropanimidamide. Molecular Formula: C14H30N2. Molecular Weight: 226.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
NNDSS - TABLE 1R. Hepatitis C, perinatal infection to Influenza-associated pediatric mortality

NNDSS - TABLE 1R. Hepatitis C, perinatal infection to Influenza-associated pediatric mortality - 2021. In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S. territories, and Non-U.S. residents.

Notice: Due to data processing issues at CDC, data for the following jurisdictions may be incomplete for week 7: Alaska, Arizona, California, Connecticut, Delaware, Florida, Hawaii, Louisiana, Maryland, Michigan, Missouri, North Dakota, New Hampshire, New York City, Oregon, Pennsylvania, and Rhode Island.

Note: 
This table contains provisional cases of national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data from the 50 states, New York City, the District of Columbia and the U.S. territories are collated and published weekly on the NNDSS Data and Statistics web page (https://wwwn.cdc.gov/nndss/data-and-statistics.html). Cases reported by state health departments to CDC for weekly publication are provisional because of the time needed to complete case follow-up. Therefore, numbers presented in later weeks may reflect changes made to these counts as additional information becomes available. The national surveillance case definitions used to define a case are available on the NNDSS web site at https://wwwn.cdc.gov/nndss/. Information about the weekly provisional data and guides to interpreting data are available at: https://wwwn.cdc.gov/nndss/infectious-tables.html. 

Footnotes:
U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
-: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
NP: Nationally notifiable but not published.
NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
Cum: Cumulative year-to-date counts.
 Max: Maximum — Maximum case count during the previous 52 weeks.
  * Case counts for reporting years 2020 and 2021 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://wwwn.cdc.gov/nndss/document/Users_guide_WONDER_tables_cleared_final.pdf. 
†Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data). 
§ Please refer to the CDC WONDER publication for weekly updates to the footnote for this condition.
Compound 525089: 2-Propenoic acid, 2,3-dichloro-, methyl ester, (Z)-

Chemical compound data from PubChem database. IUPAC Name: methyl 2,3-dichloroprop-2-enoate. Molecular Formula: C4H4Cl2O2. Molecular Weight: 154.98. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Botulinum toxin type a

DAXXIFY is a prescription injectable form of botulinum toxin type A, manufactured by Revance Therapeutics, Inc., used to temporarily improve the appearance of moderate to severe frown lines between the eyebrows in adults. It works by blocking nerve signals to muscles, reducing wrinkles. Administered via intramuscular or subcutaneous injection, it's available as a lyophilized powder for solution in vials of 100 units per 1.2 mL. Approved in September 2022 under BLA761127. This information was generated using AI and is provided for informational and research purposes only.
MD COVID-19 - Cases by ZIP Code Archive (2021)

<b>Summary</b>
The cumulative number of positive COVID-19 cases among Maryland residents within a single Maryland ZIP code for the year 2021.

<b>Description</b>
The MD COVID-19 - Cases by ZIP data layer is a collection of positive COVID-19 test results that have been reported each day by the local health department via the NEDSS system.

<b>Terms of Use</b>
The Spatial Data, and the information therein, (collectively the "Data") is provided "as is" without warranty of any kind, either expressed, implied, or statutory. The user assumes the entire risk as to quality and performance of the Data. No guarantee of accuracy is granted, nor is any responsibility for reliance thereon assumed. In no event shall the State of Maryland be liable for direct, indirect, incidental, consequential or special damages of any kind. The State of Maryland does not accept liability for any damages or misrepresentation caused by inaccuracies in the Data or as a result to changes to the Data, nor is there responsibility assumed to maintain the Data in any manner or form. The Data can be freely distributed as long as the metadata entry is not modified or deleted. Any data derived from the Data must acknowledge the State of Maryland in the metadata.

Case data aggregates to ZIP Codes do not reflect cases with missing, out of state, or incorrect ZIP Codes. Therefore, statewide totals of aggregate ZIP Code data may not match other statewide aggregate totals.
Table 12. Alcohol Use and Binge Alcohol Use in the Past Month among Individuals Aged 12 to 20, by State: Percentages, Annual Averages Based on 2013 and 2014 NSDUHs

Table 12. Alcohol Use and Binge Alcohol Use in the Past Month among Individuals Aged 12 to 20, by State: Percentages, Annual Averages Based on 2013 and 2014 NSDUHs